$8.13 -0.07 (%) Regulus Therapeutic Inc - NASDAQ

Aug. 3, 2015 | 11:12 AM

Partner Headlines

  1. Regulus Initiates Phase I Clinical Study of RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

    Benzinga | Jun. 4, 2015 | 08:04AM EST
  2. Weekly CEO Sells Highlight: Hovnanian Enterprises Inc, Regulus Therapeutics Inc, Monster ...

    GuruFocus | Apr. 27, 2015 | 02:34AM EST
  3. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 09:36AM EST
  4. Is Regulus Preparing For A Huge Breakout?

    Benzinga | Feb. 23, 2015 | 15:24PM EST
  5. Wedbush Continues Outperform Rating on Regulus

    Benzinga | Feb. 19, 2015 | 19:29PM EST
  6. Regulus Therapeutics Falls 12% Following HCV Clinical Study Results

    Benzinga | Feb. 9, 2015 | 13:19PM EST
  7. Morning Market Losers

    Benzinga | Feb. 9, 2015 | 10:00AM EST
  8. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 9, 2015 | 08:14AM EST
  10. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  11. Weekly CEO Sells Highlight: Kimberly-Clark Corp, Regulus Therapeutics Inc, Prologis Inc, and ...

    GuruFocus | Feb. 1, 2015 | 22:49PM EST
  12. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  13. Morning Market Movers

    Benzinga | Jan. 2, 2015 | 09:39AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 2, 2015 | 08:38AM EST
  15. Regulus Therapeutics Surges 11% Amid Deutsche Bank Report

    Benzinga | Nov. 24, 2014 | 15:20PM EST
  16. Morning Market Movers

    Benzinga | Nov. 24, 2014 | 09:46AM EST
  17. Morning Market Losers

    Benzinga | Nov. 13, 2014 | 09:49AM EST
  18. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 13, 2014 | 08:16AM EST
  19. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 10, 2014 | 10:17AM EST
  20. Benzinga's Volume Movers

    Benzinga | Oct. 29, 2014 | 11:23AM EST
  21. Morning Market Movers

    Benzinga | Oct. 29, 2014 | 09:46AM EST
  22. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 29, 2014 | 08:12AM EST
  23. A Quick Primer On Regulus Therapeutics And Its Upside Potential

    Benzinga | Oct. 28, 2014 | 11:19AM EST
  24. Midday Gainers From October 27: Micron Technology, Regulus Therapeutics, CyberArk Software And More

    Benzinga | Oct. 27, 2014 | 13:24PM EST
  25. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  26. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 27, 2014 | 08:21AM EST
  27. 3D Systems Slips On Profit Warning; Regulus Therapeutics Shares Spike Higher

    Benzinga | Oct. 22, 2014 | 15:29PM EST
  28. U.S. Stocks Fall; iRobot Shares Gain On Upbeat Results

    Benzinga | Oct. 22, 2014 | 14:17PM EST
  29. Markets Mostly Flat; Boeing Raises Earnings Forecast

    Benzinga | Oct. 22, 2014 | 10:42AM EST
  30. Regulus Therapeutics Soars 90% On Hepatitis C Treatment News

    Benzinga | Oct. 22, 2014 | 10:39AM EST
  31. Benzinga's Volume Movers

    Benzinga | Oct. 22, 2014 | 10:25AM EST
  32. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 22, 2014 | 10:17AM EST
  33. Morning Market Movers

    Benzinga | Oct. 22, 2014 | 09:42AM EST
  34. Regulus Therapeutics Says Glaxo Group Terminated 2008 Pact

    Benzinga | Oct. 22, 2014 | 08:52AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 22, 2014 | 08:34AM EST
  36. Wedbush Securities Reacts To Regulus Therapeutics Inc Announcing ATHENA Natural History Study

    Benzinga | Sep. 19, 2014 | 07:52AM EST
  37. S&P 500 Marks New High As Indexes Hold Gains

    IBD | Aug. 21, 2014 | 16:30PM EST
  38. Regulus Renews Strategic Alliance with Sanofi to Focus on Orphan Disease and Oncology Targets and Receives Additional $10M Equity Investment

    Benzinga | Feb. 5, 2014 | 08:06AM EST
  39. UPDATE: BMO Capital Markets Raises PT on Regulus Therapeutics Following 2Q13 Operating Results

    Benzinga | Aug. 14, 2013 | 11:18AM EST
  40. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 28, 2012 | 04:14AM EST
  41. UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress

    Benzinga | Nov. 29, 2012 | 06:35AM EST
  42. Regulus Appoints Douglas Williams, Ph.D. to its Board of Directors

    Benzinga | Nov. 7, 2012 | 01:05AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!